Decaffeinated coffee drinkers get nearly the same liver protection as those who drink regular coffee. That single finding, buried inside a 2026 study of more than 354,000 people published in Clinical Gastroenterology and Hepatology, flips the most obvious explanation for coffee’s liver benefits completely on its head. If caffeine were the active ingredient, decaf would offer nothing. The fact that it doesn’t – that it performs almost identically – tells researchers that something else in the cup is doing the heavy lifting.
The study was led by Dr. Hyunseok Kim, a transplant hepatologist and assistant professor of medicine at Cedars-Sinai Medical Center in Los Angeles. The analysis included 354,957 UK Biobank participants without cirrhosis or hepatocellular carcinoma at enrollment, followed for a median of 13 years. The scale and duration of this research set it apart from earlier, smaller studies – this wasn’t a short-term snapshot. It was more than a decade of tracking what happened to real people who drank real amounts of coffee every day.
The numbers that came out of that tracking are striking. Compared with participants who did not drink coffee, those who drank at least five cups a day were 32% less likely to develop cirrhosis, 47% less likely to develop hepatocellular carcinoma, and 42% less likely to die from liver disease. Crucially, because this is an observational study using self-reported data from a cohort that was more than 90% European, the findings show association – not proof of causation. Factors like diet quality, physical activity, and other health-conscious behaviors among regular coffee drinkers could partly explain the patterns, and the results will need validation in more diverse populations before they can be generalized broadly. With that context in mind, the researchers didn’t just count diagnoses. They assessed self-reported coffee consumption, including coffee type and whether participants added sugar or artificial sweeteners, and examined how those habits were associated with new cases of liver disease, MRI measures of liver health in a subgroup of nearly 29,000 patients, and blood protein profiles in more than 44,000 patients. That combination of clinical outcomes, imaging data, and molecular biology makes the coffee liver disease risk picture considerably clearer than it’s ever been.
1. Even One or Two Cups a Day Reduces Cirrhosis Risk
The benefits in this study weren’t all-or-nothing, reserved for people drinking five cups by noon. Participants who drank one to two cups of coffee daily showed a 20% lower risk of developing cirrhosis and a 31% lower risk of liver-related mortality compared to non-coffee drinkers. That’s a meaningful reduction for a habit most people already have.
Cirrhosis – permanent scarring of the liver that develops when healthy tissue is repeatedly damaged and replaced by scar tissue – is far more common than most people realize. CNN reported that cirrhosis is permanent liver scarring and damage that can result from several long-term liver diseases, including fatty liver disease, viral hepatitis, alcohol-related liver disease and more, especially when untreated. According to a 2023 update in the Journal of Hepatology, liver disease accounts for two million deaths annually, representing 4% of the global total, and approximately two-thirds of these fatalities occur in men.
The dose-response pattern – where more cups correlate with lower risk, up to a point – is exactly the kind of signal that gives researchers confidence the association is real rather than coincidental. A relationship that strengthens as exposure increases is one of the core criteria scientists use to assess whether an observed connection reflects a genuine biological effect. For liver health specifically, that gradient appears robust across multiple study designs.
2. The Protection Extends to Liver Cancer
According to a 2025 comprehensive review in the journal Diseases, hepatocellular carcinoma is the sixth most common cancer globally and the third leading cause of cancer-related mortality worldwide, with a five-year survival rate of only 15%. Against that backdrop, a 47% reduction in risk from a dietary habit is a number that liver specialists take seriously – even accounting for the observational design of the Cedars-Sinai study.
HCC primarily affects individuals with cirrhosis, and while viral hepatitis has historically been the predominant cause, the burden is increasingly shifting toward non-viral causes, such as alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease (MASLD). That shift matters because it means more people in everyday life – not just those with hepatitis infections – are at risk. The causes are increasingly lifestyle-driven, which makes the lifestyle-based protection that coffee appears to offer more relevant, not less.
Over the 13-year follow-up, the reduction in liver cancer cases among heavier coffee drinkers held after researchers controlled for age, sex, smoking, alcohol use, metabolic conditions, body mass index, and genetic factors. The consistent pattern across different types of drinkers – ground coffee, instant coffee, and decaf – reinforces that caffeine itself isn’t the variable responsible. Dr. Kim also acknowledged to CNN that the study’s cohort was predominantly European and relatively health-conscious, and that whether these benefits hold for more ethnically diverse populations “needs further validation.”
3. Coffee Changes What Your Liver Looks Like on an MRI
One of the most technically novel parts of the 2026 Cedars-Sinai study was its use of liver MRI data on a subset of nearly 29,000 participants. Rather than relying only on disease diagnoses, researchers could see what was happening inside the liver structurally. Participants who drank more coffee had lower levels of liver fat, liver iron, fibrosis, and liver inflammation.
Each of those markers matters independently. Excess liver fat is the foundation of non-alcoholic fatty liver disease, which can progress to fibrosis (scarring), then cirrhosis, then cancer. Elevated liver iron is associated with oxidative stress – essentially, chemical damage to liver cells from unstable molecules. Fibrosis and inflammation are the intermediate steps between a healthy liver and one that’s permanently damaged. The fact that coffee drinkers had lower readings across all four categories suggests the protection isn’t narrowly targeted at one pathway.
“The next step in our research is to identify the specific compounds in coffee that are responsible for these liver-protective associations,” said study co-author Dr. Shelly Lu, the Women’s Guild Chair in Gastroenterology and director of the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai. That specificity matters practically: once researchers pinpoint the exact compounds driving the effect, it becomes possible to study whether those compounds could be used therapeutically in people who can’t drink coffee.
4. The Active Ingredients Aren’t Caffeine – They’re Antioxidant Compounds
“We do see that probably, the liver benefit from the coffee is not from the caffeine, because we do see the similar benefit in the decaffeinated drinkers,” Dr. Kim told CNN. The conclusion the Cedars-Sinai team reached is that coffee’s protection is more closely tied to its antioxidative chemistry than to stimulant activity.
Coffee contains hundreds of bioactive compounds, but two classes in particular have drawn the most attention from liver researchers: chlorogenic acids and polyphenols. A 2025 mechanistic review in Biochemical Pharmacology found that these compounds work by activating antioxidant response pathways and inhibiting inflammatory signaling, thereby reducing oxidative stress and cellular damage, alongside supporting the liver’s detoxification enzymes. Nrf2 (nuclear factor erythroid 2-related factor 2) is essentially the liver cell’s master switch for antioxidant defense – when it’s activated, the cell becomes more resistant to the kind of oxidative damage that precedes scarring and cancer.
Research published in ScienceDirect found that chlorogenic acid increases liver antioxidant capacity through the Nrf2 pathway and protects against acute liver injury. These are largely laboratory and animal studies – preliminary cell-level data, not clinical trials – but they give the population-level findings a plausible biological mechanism, which is exactly what researchers were missing in earlier observational work.
For anyone wondering whether to switch to decaf, the answer based on current evidence is that the liver protection appears to travel with the coffee, not with the caffeine. Ground, instant, caffeinated, and decaffeinated coffee all showed similar associations with lower liver disease risk in the Cedars-Sinai findings.
5. How You Take Your Coffee Affects the Benefit
The study collected one piece of data that most coffee research overlooks: whether participants added sugar or artificial sweeteners to their cups. The answer changed the results. Participants who used sweeteners had an elevated marker for liver inflammation, which can contribute to fatty liver disease, according to Dr. Kim. Adding sugar or sweeteners to coffee appears to partially offset the protective benefit that plain coffee provides.
This finding connects logically to what’s already known about sugar’s effects on the liver. The liver is the primary organ responsible for metabolizing fructose, and excess sugar intake can drive fat accumulation in liver cells – the starting point for the fatty liver disease cascade. A cup of black coffee with antioxidant compounds working in its favor is biochemically different from a sweetened coffee drink that delivers a fructose load to the same organ those antioxidants are trying to protect.
The US Food and Drug Administration recommends limiting caffeine intake to no more than 400 milligrams per day for generally healthy adults – which amounts to about two to three 12-ounce cups of coffee. Five cups is above that caffeine threshold, which means anyone pursuing the highest-dose liver benefits should weigh caffeine sensitivity individually. Decaffeinated coffee, based on this research, sidesteps the caffeine ceiling entirely without sacrificing the liver protection that appears to be driven by other compounds.
Read More: A Massive Study Just Linked Coffee to a Significant New Side Effect
What This Means for You
The picture that emerges from this research isn’t complicated. Coffee – in its plainest form, without heaped sugar or synthetic sweeteners – appears to lower coffee liver disease risk in a dose-dependent way, starting at even one or two cups per day and becoming more pronounced at five or more. The protection spans three of the most serious liver outcomes: cirrhosis, liver cancer, and liver-related death. And because the benefit is tied to non-caffeine compounds, decaffeinated coffee counts.
Because this is a large observational study rather than a randomized controlled trial, it can’t establish that coffee directly causes better liver outcomes. Confounders – other lifestyle habits common among coffee drinkers – may contribute to some of the observed associations. Coffee should complement, not replace, established strategies for liver disease prevention. Maintaining a healthy body weight, limiting alcohol, managing blood sugar and cholesterol, and staying physically active remain the foundation of liver health. Coffee doesn’t override an otherwise high-risk lifestyle. What this research shows is that for people already living reasonably well, their daily habit may be adding a biologically meaningful layer of liver protection – one that works through antioxidant chemistry, shows up on MRI scans, and has now been tracked across more than 354,000 people for over a decade. Drink it black, or close to it. And don’t swap it for a sweetened caramel version and expect the same result.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here. AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
Read More: A 10-Year Study Compared Tea and Coffee's Effects on Bone Health - One Was the Clear Winner
The post Drinking 5 Cups of Coffee Daily May Cut Your Liver Cancer Risk by Nearly Half appeared first on The Hearty Soul.